• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    CDMOs in the Spotlight: Investing in Themselves

    Extrusion-Spheronization in OSD Manufacturing

    Modernizing Therapeutic Cell Production

    Don’t Panic! A Toxicologist’s View on Proceeding After a Clinical Hold

    Digital Transformation in Pharma
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    ValiRx Signs Lease Deal with Nottingham Laboratories

    Civica Partners with Ypsomed for Insulin Injection Pen

    Charles River Laboratories Completes the Acquisition of SAMDI Tech

    Selkirk Pharma Names New Director for Business Development

    Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing

    Upsher-Smith Opens State-of-the-Art Manufacturing Facility

    Elektrofi, Thermo Fisher Enter Strategic Contract Manufacturing Pact

    Societal CDMO Signs More Than $6M in Work Orders During 4Q22

    Genenta Science, AGC Biologics Enter Development and Manufacturing Service Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Upsher-Smith Opens State-of-the-Art Manufacturing Facility

    Beat the Supply Chain Backlog

    HPNE Launches Innovative Single-Use Assembly Service

    CDMO Selection and Tech Transfer – An Insider’s Guide to Injectables Excellence

    Catalent Bolsters Cell and Gene Services
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    ValiRx Signs Lease Deal with Nottingham Laboratories

    Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing

    Genenta Science, AGC Biologics Enter Development and Manufacturing Service Pact

    Baby Steps Toward the 21st Century

    Modernizing Therapeutic Cell Production
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Don’t Panic! A Toxicologist’s View on Proceeding After a Clinical Hold

    People and Culture Drive Operational Excellence

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Societal CDMO

    Almac Group

    Lannett CDMO

    LOTTE BIOLOGICS

    Syngene International Ltd.
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Societal CDMO

    Almac Group

    Lannett CDMO

    LOTTE BIOLOGICS

    Syngene International Ltd.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    BioCentriq Completes Tech Transfer From Avenge Bio

    Initiates manufacturing of clinical grade material to support Avenge Bio's ongoing phase 1/2 clinical trial for AVB-001.

    BioCentriq Completes Tech Transfer From Avenge Bio
    BioCentriq has successfully completed tech transfer of AVB-001 from client Avenge Bio and initiated manufacturing of clinical grade material, which will support Avenge Bio’s ongoing phase 1/2 clinical trial.
    01.18.23
    BioCentriq, a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO), has successfully completed tech transfer of AVB-001 from client Avenge Bio and initiated manufacturing of clinical grade material, which will support Avenge Bio's ongoing phase 1/2 clinical trial.

    Additionally, Avenge Bio announced on the January 9, 2023, that they successfully dosed the first patient in a first-in-human phase 1/2 clinical trial evaluating AVB-001 in relapsed refractory ovarian cancer. AVB-001, developed in the LOCOcyte platform, consists of proprietary engineered allogeneic human cells.

    "We're very enthusiastic about the advances our client has made in the development of their novel allogeneic cell therapy. Our goal now is to continue offering strong support and process development and manufacturing expertise as Avenge advances through their program," said Haro Hartounian, CEO, BioCentriq.

    Avenge Bio's first-in-human, single-arm, open-label, dose-escalation and expansion study (NCT05538624) is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of AVB-001 delivered intraperitoneally (IP) to patients with high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube.

    The cells are encapsulated in a pro-inflammatory biomaterial that are delivered to the local tumor environment and generate high, sustained concentrations of native IL-2. The product initiates a robust and durable, local and systemic immune response while avoiding toxicities associated with systemic immunotherapies.

    Doug Carlson, chief operating and financial officer at Avenge Bio, said, "This major milestone comes at a time when there are limited treatment options for those with relapsed refractory ovarian cancer. Ovarian cancer is notoriously difficult to treat and ranks fifth in cancer deaths among women. Our LOCOcyte platform addresses existing challenges and is a promising new potential treatment option for patients.
    Related Searches
    • Biologics, Proteins, Vaccines
      Loading, Please Wait..
      Trending
      • Steriline Provides Fill-Finish Solution For Berkshire Sterile Manufacturing
      • Thermo Fisher, Celltrio Partner On Cell Line Automation Platform
      • Bristol Myers Squibb 4Q Results
      • Astellas Announces New President And CEO And Management Structure
      • Bionova Expansion Project To Quadruple GMP Biologics Manufacturing Capacity
      Breaking News
      • ValiRx Signs Lease Deal with Nottingham Laboratories
      • Civica Partners with Ypsomed for Insulin Injection Pen
      • Charles River Laboratories Completes the Acquisition of SAMDI Tech
      • Selkirk Pharma Names New Director for Business Development
      • Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing
      View Breaking News >
      CURRENT ISSUE

      January/February 2023

      • CDMOs in the Spotlight: Investing in Themselves
      • Extrusion-Spheronization in OSD Manufacturing
      • Modernizing Therapeutic Cell Production
      • Don’t Panic! A Toxicologist’s View on Proceeding After a Clinical Hold
      • Digital Transformation in Pharma
      • Fill-Finish in Cell & Gene Therapy
      • Early-Stage Biotechs: What’s Essential and What’s Not
      • Five Insights to Maximize Customer-Centric Acquisition Growth
      • Challenges in API Technical Transfer
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      ADM Expands Production to Meet Demand for Probiotics
      Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA
      FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder
      Coatings World

      Latest Breaking News From Coatings World

      Personnel Changes at BASF
      Dr. Kurt Wood to Deliver Mattiello Memorial Lecture at ACA’s 2023 CoatingsTech Conference
      hubergroup Chemicals to Debut at the European Coatings Show
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Konica Minolta Introduces Mobile X-Ray Systems to Latin America
      NIH MedTech Program Aims to Develop Neurological Treatment Tech
      Formula Plastics Appoints Bill Gerard as President
      Contract Pharma

      Latest Breaking News From Contract Pharma

      ValiRx Signs Lease Deal with Nottingham Laboratories
      Civica Partners with Ypsomed for Insulin Injection Pen
      Charles River Laboratories Completes the Acquisition of SAMDI Tech
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Tree Hut Introduces Body Wash Line
      Zara Introduces Mini Artists—Beauty Products for Kids
      L’Oréal USA Taps Stephanie Kramer as Chief Human Resources Officer
      Happi

      Latest Breaking News From Happi

      FTC Extends Public Comment Period on Potential Updates to Green Guides
      Arm & Hammer Taps Dave & Jenny Marrs, TikTokers for Budget-Centered 'Give It The Hammer' Campaign
      Meaningful Beauty Age-Proof Hair Care System Now Available on Amazon
      Ink World

      Latest Breaking News From Ink World

      Siegwerk, Wildplastic, TU-Hamburg Partner on Deinking
      Brilliant Group and Terra Firm Launch Partnership
      hubergroup Chemicals Debuts at the European Coatings Show
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      The Oldham Group names Doug McClure technical sales rep
      Siegwerk partnership aims to improve plastic waste recyclability
      CELAB-Europe launches new web hub for liner recyclers
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Hospeco Offers TaskBrand Prep-Paint-Finish Wiping System
      Toray to Expand PPS Production in Korea
      Masque Bar Launches Compostable Sheet Masks
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      OSSIO Introduces Non-Permanent Compression Staple
      Dennis Jones Joins Intelivation Technologies as Manufacturing VP
      Jury Convicts Chiropractor, Orthopedic Surgeon in $31M Fraud Scheme
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Nedap Follows NRF Success with Showcase at EuroShop 2023
      NXP Semiconductors Reports 4Q, Full-Year 2022 Results
      Zebra Technologies Extends Partnership with the NFL

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login